Tuesday, July 16, 2024

Exploring the Impact of Pharmacist Experience on Health Outcomes in Metabolic Syndrome Patients

Similar articles

Patients with metabolic syndrome (MetS) often grapple with poor health outcomes due to inadequate utilization of disease management resources. This phenomenon might be significantly influenced by their prior experiences with pharmacists (PEwP) and their perceptions of disease management resource utilization (PMU). Understanding these experiences could be pivotal in enhancing patient perceptions and ultimately improving health-related quality of life (HRQoL).

The study aimed to investigate the effect of PEwP and PMU on the HRQoL of individuals suffering from MetS. Data were gathered through an electronic survey employing validated tools to assess healthcare, medication, and pharmacy service utilization, alongside PEwP and HRQoL. The study utilized chi-square and ordinal regression tests to analyze the association between PMU, PEwP, and HRQoL. Additionally, mediation analysis via Haye’s model 4 was implemented to explore both direct and indirect relationships between PMU and PEwP on HRQoL.

Key Findings

A total of 706 survey responses were analyzed, revealing that, on average, respondents reported three comorbidities. Approximately 72.0% of participants had positive PEwP, while 32.6% demonstrated favorable PMU. Among those with good PEwP, 38.4% also had good PMU, compared to 17.3% among those with poor PEwP. Furthermore, 47.0% of individuals with good PMU enjoyed good HRQoL, as opposed to 35.3% with poor PMU.

The analysis indicated that participants with good PEwP had nearly three times the odds (OR = 2.97, p

Implications for Healthcare

Mediation analysis through bootstrap methods showed a significant connection between PEwP and HRQoL via PMU (BootCI = -0.072, -0.022). This underscores the crucial role of pharmacists in shaping patients’ perceptions and utilization of disease management resources, which in turn affects their HRQoL.

Concrete Inferences for Healthcare Providers

– Positive prior experiences with pharmacists significantly enhance the likelihood of better disease management resource utilization.
– Enhanced disease management resource utilization directly correlates with improved health-related quality of life in MetS patients.
– Interventions aimed at improving patient-pharmacist interactions could indirectly bolster HRQoL by optimizing resource utilization perceptions.

The study concludes that individuals with MetS who have favorable experiences with pharmacists and better disease management resource utilization are more likely to experience improved HRQoL. Pharmacists should actively consider patients’ experiences and perceptions of management utilization to foster better health outcomes among those with MetS through targeted interventions.

Original Article: Explor Res Clin Soc Pharm. 2024 May 25;14:100457. doi: 10.1016/j.rcsop.2024.100457. eCollection 2024 Jun.

You can follow our news on our Telegram and LinkedIn accounts.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article